US · Healthcare

Ono Pharmaceutical Co Ltd (OPHLY)

Drug Manufacturers - General

Ono Pharmaceutical Co Ltd (OPHLY) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - General. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for OPHLY

P/E ratio

18.00

Ono Pharmaceutical Co Ltd (OPHLY) — FAQ

What is OPHLY's P/E ratio?

The price-to-earnings (P/E) ratio for Ono Pharmaceutical Co Ltd (OPHLY) is 18.00 (data as of 2026-03-24).

Does Ono Pharmaceutical Co Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Ono Pharmaceutical Co Ltd (OPHLY). Check the MyAverix Finance app for the latest dividend data.

What sector is Ono Pharmaceutical Co Ltd in?

Ono Pharmaceutical Co Ltd (OPHLY) is classified in the Healthcare sector (Drug Manufacturers - General industry).

What exchange is OPHLY listed on?

OPHLY is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)